These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 4548947
21. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999 [Abstract] [Full Text] [Related]
22. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases]. Krulik M, Tobelem G, Audebert AA, Mougeot-Martin M, Debray J. Ann Med Interne (Paris); 1977 Jan; 128(1):57-62. PubMed ID: 855970 [No Abstract] [Full Text] [Related]
23. Diagnostic methodologies for circulating anticoagulants. Exner T. Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481 [Abstract] [Full Text] [Related]
24. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor]. Komiyama Y, Munakata M, Masuda M, Kagawa H, Fukuhara S, Takahashi H. Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416 [Abstract] [Full Text] [Related]
25. [Detection of blood coagulation inhibitors using a modified Lossing-Kasper test]. Meili EO, Büchter U, von Felten A. Schweiz Med Wochenschr; 1986 Oct 25; 116(43):1492-4. PubMed ID: 3097819 [Abstract] [Full Text] [Related]
26. Investigations of the lupus-like inhibitor by-passing activity of platelets. Howard MA, Firkin BG. Thromb Haemost; 1983 Dec 30; 50(4):775-9. PubMed ID: 6420922 [Abstract] [Full Text] [Related]
28. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII). Rizza CR, Edgcumbe JO, Pitney WR, Child JA. Thromb Diath Haemorrh; 1972 Aug 31; 28(1):120-8. PubMed ID: 5074988 [No Abstract] [Full Text] [Related]
29. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition. Goldsmith GH, Silverman P. J Lab Clin Med; 1985 Sep 31; 106(3):279-85. PubMed ID: 3875671 [Abstract] [Full Text] [Related]
30. [Anti-phospholipid antibodies as a cause of immunologic thrombopenia and thrombopathies]. von Felten A, Gehrig D, Martius F. Schweiz Med Wochenschr; 1977 Oct 15; 107(41):1465. PubMed ID: 918601 [Abstract] [Full Text] [Related]
31. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. Firkin BG, Booth P, Hendrix L, Howard MA. Am J Hematol; 1978 Oct 15; 5(2):81-92. PubMed ID: 736036 [Abstract] [Full Text] [Related]
33. Naturally occurring anticoagulants: a case report. Ross SA. N Z Med J; 1968 Mar 15; 67(430):411-3. PubMed ID: 4968117 [No Abstract] [Full Text] [Related]
37. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases]. Liozon E, Delaire L, Turlure P, Jaccard A, Loustaud-Ratti V, Réméniéras L, Julia A, Gaillard S, Bordessoule D, Vidal E. Ann Med Interne (Paris); 1997 Mar 15; 148(7):477-90. PubMed ID: 9538386 [Abstract] [Full Text] [Related]
39. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. Edson JR, Krivit W, White JG. J Lab Clin Med; 1967 Sep 15; 70(3):463-70. PubMed ID: 6072020 [No Abstract] [Full Text] [Related]